HSPA1A and Alzheimer disease: HSPA1A gene expression was down-regulated in late stage AD compared to early stage in the prefrontal cortex [69] and its protein level was also downregulated in AD brain [68], suggesting that increased levels of HSPA1A in CSF EV may represent neuronal cell loss in the affected brain regions.